Treace Medical Concepts
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $45,376 | $47,198 | $62,519 | $50,214 |
Gross Profit | 35,607 | 37,407 | 50,401 | 39,706 |
EBITDA | -12,423 | -15,492 | -5,163 | -12,172 |
EBIT | -14,311 | -16,391 | -8,044 | -14,950 |
Net Income | -15,873 | -17,961 | -9,394 | -16,288 |
Net Change In Cash | 45,376 | 47,198 | 62,519 | 50,214 |
Free Cash Flow | -6,899 | 4,171 | -10,424 | -11,901 |
Cash | 12,610 | 9,544 | 10,708 | 7,686 |
Basic Shares | 65,049 | 64,592 | 63,860 | 63,515 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $212,690 | $209,357 | $187,118 | $141,838 |
Gross Profit | 169,752 | 168,264 | 151,937 | 114,315 |
EBITDA | -43,182 | -42,068 | -39,008 | -36,284 |
EBIT | -53,682 | -50,487 | -44,360 | -38,417 |
Net Income | -59,002 | -55,743 | -49,527 | -42,815 |
Net Change In Cash | 212,690 | 209,357 | 187,118 | 141,838 |
Cost of Revenue | -86,360 | |||
Free Cash Flow | -29,487 | -48,760 | -46,033 | -45,486 |
Cash | 10,708 | 11,350 | 12,982 | 19,473 |
Basic Shares | 63,269 | 62,112 | 60,852 | 55,276 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.24 |
2026-03-31 | -$0.28 |
2025-12-31 | -$0.07 |
2025-09-30 | -$0.22 |